首页> 外文期刊>Analytical methods >Analysis of N-methylpyrrolidine in cefepime hydrochloride by ion chromatography using suppressed conductivity detection with solid-phase extraction pre-treatment
【24h】

Analysis of N-methylpyrrolidine in cefepime hydrochloride by ion chromatography using suppressed conductivity detection with solid-phase extraction pre-treatment

机译:离子色谱-固相萃取预处理-抑制电导检测离子色谱法分析盐酸头孢吡肟中的N-甲基吡咯烷

获取原文
           

摘要

N-Methylpyrrolidine (NMP) is the principal hydrolysis product of cefepime hydrochloride, a ?2-lactam antibiotic. NMP is limited in cefepime hydrochloride by current regulations to not more than 0.3% w/w. Existing methods for the liquid-phase chromatographic analysis of this impurity fail to separate NMP from the drug substance prior to analysis, with the result that NMP continues to be formed by hydrolysis of cefepime in the final analytical solution. This study proposes a simple, rapid solid-phase extraction procedure that separates NMP from cefepime hydrochloride prior to analysis. NMP was separated from the majority of cefepime in the sample solution using polymeric reverse phase solid-phase extraction. Recovery, precision, sensitivity, linearity and specificity values were adequate to support the use of this method for regulatory purposes. The relative amount of NMP formed in sample extracts processed by solid-phase extraction was at least five times less compared to untreated samples.
机译:N-甲基吡咯烷(NMP)是盐酸头孢吡肟(β2-内酰胺类抗生素)的主要水解产物。根据现行法规,盐酸头孢吡肟中的NMP含量不得超过0.3%w / w。用于该杂质的液相色谱分析的现有方法未能在分析之前将NMP从原料药中分离出来,其结果是,在最终分析溶液中,头孢吡肟的水解继续形成NMP。这项研究提出了一种简单,快速的固相萃取程序,可在分析之前将NMP与盐酸头孢吡肟分离。使用聚合物反相固相萃取将NMP与样品溶液中的大多数头孢吡肟分离。回收率,精密度,灵敏度,线性和特异性值足以支持将此方法用于监管目的。与未经处理的样品相比,通过固相萃取处理的样品萃取物中形成的NMP的相对量至少少五倍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号